These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11129427)
1. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. MacLeod SL; Nowell S; Plaxco J; Lang NP Ann Surg Oncol; 2000 Dec; 7(10):777-82. PubMed ID: 11129427 [TBL] [Abstract][Full Text] [Related]
2. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. Park J; Chen L; Shade K; Lazarus P; Seigne J; Patterson S; Helal M; Pow-Sang J J Urol; 2004 Jun; 171(6 Pt 1):2484-8. PubMed ID: 15126881 [TBL] [Abstract][Full Text] [Related]
3. Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis. Zhong X; Feng J; Xiao Y; Wang P; Fan Q; Wu R; Hu W; Huang C Oncotarget; 2017 Aug; 8(32):52837-52845. PubMed ID: 28881775 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Lévesque E; Beaulieu M; Green MD; Tephly TR; Bélanger A; Hum DW Pharmacogenetics; 1997 Aug; 7(4):317-25. PubMed ID: 9295060 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Lampe JW; Bigler J; Bush AC; Potter JD Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):329-33. PubMed ID: 10750673 [TBL] [Abstract][Full Text] [Related]
6. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score. Hajdinjak T; Zagradisnik B Prostate; 2004 Jun; 59(4):436-9. PubMed ID: 15065092 [TBL] [Abstract][Full Text] [Related]
8. Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk. Grant DJ; Hoyo C; Oliver SD; Gerber L; Shuler K; Calloway E; Gaines AR; McPhail M; Livingston JN; Richardson RM; Schildkraut JM; Freedland SJ Genet Test Mol Biomarkers; 2013 Jan; 17(1):3-9. PubMed ID: 23098242 [TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. Chouinard S; Barbier O; Bélanger A J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572 [TBL] [Abstract][Full Text] [Related]
10. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells. Hu DG; Mackenzie PI Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324 [TBL] [Abstract][Full Text] [Related]
11. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035 [TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. Gsur A; Preyer M; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):497-8. PubMed ID: 12010866 [No Abstract] [Full Text] [Related]
13. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver. Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558 [TBL] [Abstract][Full Text] [Related]
14. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996 [TBL] [Abstract][Full Text] [Related]
15. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Karypidis AH; Olsson M; Andersson SO; Rane A; Ekström L Pharmacogenomics J; 2008 Apr; 8(2):147-51. PubMed ID: 17387331 [TBL] [Abstract][Full Text] [Related]
16. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Hanioka N; Oka H; Nagaoka K; Ikushiro S; Narimatsu S Arch Toxicol; 2011 Nov; 85(11):1373-81. PubMed ID: 21404072 [TBL] [Abstract][Full Text] [Related]
17. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study. Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566 [TBL] [Abstract][Full Text] [Related]
18. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. Gauthier-Landry L; Bélanger A; Barbier O J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263 [TBL] [Abstract][Full Text] [Related]
19. Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population. Okugi H; Nakazato H; Matsui H; Ohtake N; Nakata S; Suzuki K Cancer Detect Prev; 2006; 30(3):262-8. PubMed ID: 16859836 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]